Ceppi, M., Driessens, G., Claes, B., Ma, S., Henau, O. D., Cuende, J., . . . Libouban, M. (2023). 74 a-TIGIT mAb belrestotug in combination with anti-PD1 induces an immunocompetent tumor microenvironment (TME). BMJ Publishing Group.
Chicago Style (17th ed.) CitationCeppi, Maurizio, et al. 74 a-TIGIT MAb Belrestotug in Combination with Anti-PD1 Induces an Immunocompetent Tumor Microenvironment (TME). BMJ Publishing Group, 2023.
MLA (9th ed.) CitationCeppi, Maurizio, et al. 74 a-TIGIT MAb Belrestotug in Combination with Anti-PD1 Induces an Immunocompetent Tumor Microenvironment (TME). BMJ Publishing Group, 2023.
Warning: These citations may not always be 100% accurate.